310 related articles for article (PubMed ID: 24091326)
21. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.
White-Gilbertson S; Lu P; Norris JS; Voelkel-Johnson C
J Lipid Res; 2019 Jul; 60(7):1225-1235. PubMed ID: 30988134
[TBL] [Abstract][Full Text] [Related]
22. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
Chou FJ; Chen Y; Chen D; Niu Y; Li G; Keng P; Yeh S; Chang C
EBioMedicine; 2019 Feb; 40():504-516. PubMed ID: 30692044
[TBL] [Abstract][Full Text] [Related]
23. Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer.
Clifford RE; Govindarajah N; Bowden D; Sutton P; Glenn M; Darvish-Damavandi M; Buczacki S; McDermott U; Szulc Z; Ogretmen B; Parsons JL; Vimalachandran D
Cells; 2020 Dec; 9(12):. PubMed ID: 33334013
[TBL] [Abstract][Full Text] [Related]
24. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
Xu L; Yang D; Wang S; Tang W; Liu M; Davis M; Chen J; Rae JM; Lawrence T; Lippman ME
Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891
[TBL] [Abstract][Full Text] [Related]
25. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.
Nava VE; Cuvillier O; Edsall LC; Kimura K; Milstien S; Gelmann EP; Spiegel S
Cancer Res; 2000 Aug; 60(16):4468-74. PubMed ID: 10969794
[TBL] [Abstract][Full Text] [Related]
27. STAT3 as a target for sensitizing prostate cancer cells to irradiation.
Zhang Q; Zhou XM; Wei SZ; Cui DS; Deng KL; Liang G; Luo Y; Luo B; Liang XJ
J Radiat Res; 2022 Mar; 63(2):174-182. PubMed ID: 34970978
[TBL] [Abstract][Full Text] [Related]
28. Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis.
Cho SM; Kwon HJ
Arch Pharm Res; 2019 Mar; 42(3):232-243. PubMed ID: 30661200
[TBL] [Abstract][Full Text] [Related]
29. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
30. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
[TBL] [Abstract][Full Text] [Related]
31. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
[TBL] [Abstract][Full Text] [Related]
32. The Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation.
Rajagopalan K; Qiu R; Mooney SM; Rao S; Shiraishi T; Sacho E; Huang H; Shapiro E; Weninger KR; Kulkarni P
Biochim Biophys Acta; 2014 Feb; 1842(2):154-63. PubMed ID: 24263171
[TBL] [Abstract][Full Text] [Related]
33. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
[TBL] [Abstract][Full Text] [Related]
34. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells.
Taniai T; Shirai Y; Shimada Y; Hamura R; Yanagaki M; Takada N; Horiuchi T; Haruki K; Furukawa K; Uwagawa T; Tsuboi K; Okamoto Y; Shimada S; Tanaka S; Ohashi T; Ikegami T
Cancer Sci; 2021 Nov; 112(11):4570-4579. PubMed ID: 34459070
[TBL] [Abstract][Full Text] [Related]
36. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
[TBL] [Abstract][Full Text] [Related]
37. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.
Elojeimy S; Liu X; McKillop JC; El-Zawahry AM; Holman DH; Cheng JY; Meacham WD; Mahdy AE; Saad AF; Turner LS; Cheng J; A Day T; Dong JY; Bielawska A; Hannun YA; Norris JS
Mol Ther; 2007 Jul; 15(7):1259-63. PubMed ID: 17426710
[TBL] [Abstract][Full Text] [Related]
38. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
39. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
40. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation.
Pang XL; He G; Liu YB; Wang Y; Zhang B
World J Gastroenterol; 2013 Mar; 19(11):1736-48. PubMed ID: 23555162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
